No description available.

Alzheimer’s disease (AD) is a neurodegenerative disorder, with extensive evidence implicating the misfolding, aggregation and deposition of the amyloid-β (Aβ) peptide as central to the pathogenesis. Heparan sulfate (HS) is an interactive glycosaminoglycan, attached to core proteins as HS proteoglycans (HSPGs). HSPGs are present on cell surfaces and in the extracellular matrix where they facilitate multiple signaling functions, but HS is also consistently present in all amyloid deposits, including those of AD. In amyloidosis HS has been studied as an aggregation template, promoting fibril formation and serving a scaffold function in the resulting deposits. The objective of this thesis was to assess how cell surface HS is potentially implicated in Aβ amyloidosis and the associated neuroinflammation of AD.   In AD brain we determined that HS predominantly accumulated in Aβ deposits with dense cores and found glial-expressed HSPGs within these deposits. Aβ elevated HSPG levels in primary glial cultures, implicating activated glia as one source of the Aβ-associated HS. Next, we determined that microglial HSPGs are critical for the upregulation of interleukin-1β and tumor necrosis factor-α following exposure to lipopolysaccharide, an established inflammatory insult. Together these results raise the possibility that Aβ-induced expression of microglial HSPGs may promote neuroinflammation.   Multiple mechanisms of Aβ toxicity have been proposed and different Aβ assemblies exert their toxicity through alternative routes. We found that three different preparations of Aβ aggregates all exhibited HS-dependent cytotoxicity, which in part correlated with Aβ internalization. Furthermore, heparin treatment attenuated Aβ cytotoxicity and uptake. In Aβ-positive AD microvasculature, HS deposited with Apolipoprotein E (ApoE) and its receptor, the low density lipoprotein receptor-related protein 1 (LRP1). In cell culture, HS and LRP1 co-operated in Aβ interactions and the addition of ApoE increased the levels of cell-associated Aβ in a HS- and LRP1-dependent manner. This ApoE-mediated increase in cell-associated Aβ may promote toxicity and vascular degeneration, but equally HS-mediated internalization of Aβ could represent a clearance route across the blood-brain-barrier. The findings presented here illustrate multiple roles for cell-surface HSPGs in interactions relevant to the pathogenesis of AD.

B virus is an alphaherpesvirus, endemic to macaque monkeys, capable of deadly human zoonosis with an 80% mortality rate in untreated cases. The macaque monkey is widely used in biomedical research and the threat of B virus poses an occupational hazard to researchers, veterinarians, and animal handlers. B virus establishes a life-long latent infection in sensory neurons of the peripheral nervous system (PNS) in the natural host. In human infections, B virus readily transits to the central nervous system (CNS) and destroys brain tissues. Identifying immune correlates of B virus infection in the PNS of the natural host is critical in understanding viral lethality in the human host. The lack of an accurate animal model and restrictions on handling potentially infected nervous tissue previously limited studies of B virus infection in macaque ganglia. To address this barrier, a long-lived mixed neuron/glia cell culture model was established from macaque DRG explants using a novel methodology that relied on cellular migration from whole tissues. Utilizing this model, the hypothesis tested was that acute B virus infection of macaque ganglia triggers cellular defense networks to promote leukocyte recruitment and impact leukocyte activation. Chemokines were upregulated in B virus-infected cultures and infected cell media induced leukocyte chemotaxis. Leukocytes were less effectively activated by media from infected cells when compared to media from mock-infected cells. To identify factors responsible for this, focused microarrays were performed and cytokine profiles were quantified from B virus and mock-infected culture supernatants. IL-6 protein levels were significantly reduced in B virus infected cultures. This observation led to the hypothesis that IL-6 downregulation impairs leukocyte activation and, indeed, when IL-6 was added to B virus-infected culture supernatants to control levels, these cultures were far more effective at eliciting leukocyte activation when compared with mock-infected cultures. Collectively, these data support the hypothesis that acute B virus infection of macaque ganglia triggers cellular defense networks to promote leukocyte recruitment and impact leukocyte activation and identifies a potential viral mechanism to impair leukocyte functionality. Additionally, this work presents a novel methodology for establishing long-lived mixed neuron/glia cultures from postnatal/adult macaque DRGs.

Ultra-low doses (ULD) of the opioid receptor antagonists, naloxone and naltrexone, augment the analgesic actions of morphine, block the induction of tolerance, and reverse established tolerance by an unknown mechanism. Preclinical studies demonstrate that chronic morphine administration induces spinal gliosis and that inhibition of gliosis prevents the development of analgesic tolerance to opioids. Thus, this thesis investigated the inhibition of spinal gliosis as a mechanism by which ULD antagonists attenuate analgesic tolerance and opioid-induced hyperalgesia. Immune cell activation is implicated in the etiology of morphine tolerance and intrathecal catheterization, a technique commonly used to study the spinal effects of drugs, causes profound gliosis. Thus, the first study investigated the effects of catheter-induced gliosis on acute and chronic morphine analgesic tolerance. Catheterization-induced gliosis did not alter antinociceptive responses to acute intrathecal morphine; however, tolerance to chronic morphine was exacerbated in catheterized rats compared to sham and surgery-naïve controls. The potentiation of analgesic tolerance to chronic morphine by spinal gliosis provided evidence that glia modulate opioid analgesia; therefore, inhibition of opioid-induced activation of glia was explored as a potential mechanism by which ULD antagonists prevent tolerance. The second series of experiments reported morphine-induced activation of spinal microglia and astrocytes was blocked by co-administering ULD naltrexone with morphine. These findings prompted us to elucidate the specific molecular target through which ULD antagonists attenuate opioid analgesia. Activation of glial Toll-like receptor 4 (TLR4) induces gliosis and may contribute to analgesic tolerance and/or morphine-induced hyperalgesia (MIH). Antagonism of TLR4 by the opioid receptor-inactive (+) stereoisomer of naloxone was identified as a potential mechanism by which ULD antagonists modulate opioid analgesia. Tolerance and MIH developed in mice expressing non-functional TLR4 and in wildtype controls. Analgesic tolerance was stereoselectively blocked by ULD (-)naloxone, whereas MIH was blocked by both naloxone enantiomers. Collectively, these studies demonstrate analgesic tolerance and MIH occur through distinct mechanisms. ULD naloxone attenuates analgesic tolerance likely via an opioid receptor-mediated mechanism that is TLR4-independent. ULD antagonists do not attenuate tolerance via inhibition of spinal gliosis as hypothesized. In contrast, ULD antagonists prevent MIH by inhibiting opioid-induced gliosis in an opioid receptor- and TLR4-independent manner. Immune cell activation is implicated in the etiology of morphine tolerance and intrathecal catheterization, a technique commonly used to study the spinal effects of drugs, causes profound gliosis. Thus, the first study investigated the effects of catheter-induced gliosis on acute and chronic morphine analgesic tolerance. Catheterization-induced gliosis did not alter antinociceptive responses to acute intrathecal morphine; however, tolerance to chronic morphine was exacerbated in catheterized rats compared to sham and surgery-naïve controls. The potentiation of analgesic tolerance to chronic morphine by spinal gliosis provided evidence that glia modulate opioid analgesia; therefore, inhibition of opioid-induced activation of glia was explored as a potential mechanism by which ULD antagonists prevent tolerance. The second series of experiments reported morphine-induced activation of spinal microglia and astrocytes was blocked by co-administering ULD naltrexone with morphine. These findings prompted us to elucidate the specific molecular target through which ULD antagonists attenuate opioid analgesia. Activation of glial Toll-like receptor 4 (TLR4) induces gliosis and may contribute to analgesic tolerance and/or morphine-induced hyperalgesia (MIH). Antagonism of TLR4 by the opioid receptor-inactive (+) stereoisomer of naloxone was identified as a potential mechanism by which ULD antagonists modulate opioid analgesia. Tolerance and MIH developed in mice expressing non-functional TLR4 and in wildtype controls. Analgesic tolerance was stereoselectively blocked by ULD (-)naloxone, whereas MIH was blocked by both naloxone enantiomers. Collectively, these studies demonstrate analgesic tolerance and MIH occur through distinct mechanisms. ULD naloxone attenuates analgesic tolerance likely via an opioid receptor-mediated mechanism that is TLR4-independent. ULD antagonists do not attenuate tolerance via inhibition of spinal gliosis as hypothesized. In contrast, ULD antagonists prevent MIH by inhibiting opioid-induced gliosis in an opioid receptor- and TLR4-independent manner. / Thesis (Ph.D, Pharmacology & Toxicology) -- Queen's University, 2013-04-25 15:06:50.731

Les hétérotopies nodulaires périventriculaires (HNP) correspondent aux malformations cérébrales les plus fréquemment découvertes à l'âge adulte. Survenant au cours de la migration, elles consistent en l'apparition de nodules de neurones ectopiques positionnés le long de la paroi des ventricules latéraux. Sur le plan clinique, les HNP associent une épilepsie et/ou un retard mental. Les mutations dans le gène FLNA (Xq28) représentent la cause majeure des HNP. Une forme récessive rare d'HNP liée à des mutations du gène ARFGEF2 (20q13) et des réarrangements chromosomiques identifiés chez des patients présentant une HNP ont également été rapportés. Alors que le lien entre les HNP associées à des mutations du gène FLNA et leurs manifestations cliniques a été clairement établi, les mécanismes physiopathologiques sous-jacents restent à ce jour inconnus. Deux lignées de souris knockout pour FlnA ont été développées mais aucune de ces deux lignées n'a développé d'HNP. Nous avons donc choisi de créer un nouveau modèle, chez le rat, par inactivation in utero du gène FlnA en utilisant la technique de l'ARN interférence (RNAi). Par cette approche, nous avons reproduit avec succès un phénotype d'HNP chez le rat comparable à celui observé chez les patients. Sur ce modèle, nous avons montré que l'HNP est associée à une désorganisation de la glie radiaire et à une incapacité des progéniteurs neuronaux de progresser dans le cycle cellulaire. En accord avec ces observations, une désorganisation de la glie radiaire a été également observée dans des cerveaux post-mortem de deux patientes présentant une HNP associée à une mutation de FLNA. / Periventricular nodular heterotopia (PNH) is a brain malformation caused by defective neuronal migration resulting in ectopic neuronal nodules lining the lateral ventricles. Most patients have epilepsy, with normal to borderline cognitive function. Mutations in FLNA are the main cause of PH. A rare recessive form caused by mutations in the ARFGEF2 gene (20q13) and chromosomal rearrangements identified in patients with PNH have been reported. The link between FLNA-trelated PH and clinical manifestattions has been wee established but the underlying pathological mechanism remains unknown. Though two FlnA knockout mice strains have been developed, progress has been hindered by the fact that none of them showed the presence of ectopic nodules. Therefore, to recapitulate the loss of FlnA function in the developing rat brain, we used an in utero RNA interference (RNAi)-mediated knockdown approach and successfully reproduced a PNH phenotype in rats comparable to that observed in patients. Using this FlnA knockdown rodent model, we demonstrated that PNH is associated with a disruption in radial glial scaffold integrity in the ventricular zone and also an inability for neuroprogenitor cells to progress adequately through the cell cycle.Consistent with the observations made in rodents, we found similar alterations of radial glia in postmortem brains of two PNH patients harboring distinct FLNA mutations. These data highlights the complexity of the pathogenesis of PNH, the likelihood that several mechanisms are coalescing to lead to disrupted neuronal migration.

Dans le présent travail, le rôle de la glie dans l’expression de la douleur cancéreuse et de la douleur neuropathique a été étudié de façon comparative. Le modèle animal de douleur cancéreuse a été obtenu par injection osseuse dans le tibia, chez la rate Sprague-Dawley, de cellules de carcinome mammaire de type MRMT-1. Le modèle de douleur neuropathique a été obtenu chez le rat Wistar par ligature des nerfs spinaux L5 et L6. Les données obtenues par l’analyse du comportement douloureux en réponse à la stimulation par des filaments de von Frey ont permis de quantifier l’allodynie et l’hyperalgésie mécaniques statiques. La douleur chronique, hors stimulation nociceptive, a été mesurée à l’aide d’un test d’impotence. Les agents pharmacologiques ont été administrés par voie intrapéritonéale ou par voie intrathécale, à l’aide d’un cathéter implanté de façon chronique. L’analyse des comportements nociceptifs après stimulation par filaments de von Frey montre que l’inhibition fonctionnelle transitoire de la glie spinale par le fluorocitrate est sans effet sur la douleur dans les deux modèles. Dans les deux modèles, l’expression des réponses douloureuses dépend de l’activation des récepteurs NMDA spinaux. L’administration par voie intrathécale d’une seule dose de D-aminoacide oxydase, qui dégrade la D-sérine, co-agoniste endogène du récepteur NMDA, réduit l’allodynie et l’hyperalgésie chez les rats neuropathiques et l’allodynie chez les rats cancéreux. Les effets d’un traitement chronique par le fluoroacétate chez les rats neuropathiques sont réversés par l’administration intrathécale de D-sérine. La D-sérine altère légèrement le seuil nociceptif chez les rats cancéreux. Aucun des agents pharmacologiques utilisés ne réverse la réduction d’appui du membre lésé chez les rats cancéreux ou neuropathiques. Ces résultats montrent que, chez le rat, la douleur neuropathique comme la douleur osseuse cancéreuse dépend de la co-activation des récepteurs NMDA spinaux par un de ses ligands endogènes, la D-sérine, mais que seule la douleur neuropathique requiert une glie spinale fonctionnelle. Ils suggèrent donc un rôle différentiel de la glie dans la physiopathologie de ces deux types de douleur chronique / The present work has investigated the role of glia upon pain symptoms in a well established peripheral neuropathic pain model and a bone cancer pain model. The neuropathic pain model was obtained by right L5-L6 spinal nerve ligation in male Wistar rats. Bone cancer pain was induced by injecting MRMT-1 rat mammary gland carcinoma cells into the right tibia of Sprague-Dawley female rats. Mechanical allodynia and hyperalgesia were quantified using von Frey hairs and ambulatory incapacitance using dynamic weight bearing. Drugs were administered either acutely or chronically using osmotic pumps, through intrathecal catheters chronically implanted in experimental animals. Using von Frey hair stimuli, we found that transient inhibition of glia metabolism by intrathecal injection of fluorocitrate was ineffective in both models. In both models, pain symptoms required spinal NMDA receptor activation. Intrathecal administration of a single dose of D-aminoacid oxidase, which degrades D-serine, a co-agonist of NMDA receptors, reduced mechanical allodynia and hyperalgesia in neuropathic rats and allodynia in cancer rats. The effect of chronic fluoroacetate in neuropathic rats was reversed by acutely administered intrathecal D-serine, which had only a slight effect in cancer rats. None of these compounds altered the functional disability shown by neuropathic or cancer animals and measured by the dynamic weight bearing apparatus. These results show that neuropathic pain and cancer pains depend upon D-serine co-activation of spinal NMDA receptors but only neuropathic pain requires functional spinal cord glia in the rat. Glia may thus play different roles in the development and maintenance of chronic pain in these two situations.

Le bon fonctionnement des réseaux neuronaux dépend des interactions entre les neurones et les cellules gliales. Alors que de nombreux efforts ont été faits pour comprendre les interactions entre les neurones, moins est connu sur la nature des interactions entre les cellules gliales ; ceci est due à la complexité du système nerveux des vertébrés, qui comprend plus de cellules gliales que de neurones. Cependant, le système nerveux de la drosophile à un rapport neurones-cellules gliales faible, ce qui fait de cet animal simple un modèle idéal pour évaluer ce concept. J’ai utilisé des approches génétiques à résolution cellulaire pour disséquer les mécanismes cellulaires et moléculaires de la migration collective des cellules gliales in vivo. En résumé, mes données révèlent les bases du mécanisme contrôlant la migration cellulaire collective : 1) les cellules du front de migration interagissent entre elles en amont et en aval et 2) N-cad est nécessaire pour une migration optimal de la glie. / The functionality of the complex neural network depends on the interactions between neurons and glia. While many efforts have been made to understand the neuron-neuron interactions, less is known about those amongst glial cells. Due to the complexity of the vertebrate nervous system, which comprises manifold more glia than neurons, it is hard to tackle the role of glia-glia interactions. The nervous system of Drosophila, however, has a lower glia-neuron ratio, which makes this simple animal an ideal model. I use genetic approaches at cellular resolution to dissect the cellular and molecular mechanisms of glial collective migration in vivo. In Sum, I have shown some basic mechanism controlling collective cell migration: 1) cells at the front of the collective interact with each other through anterograde and retrograde bidirectional interaction. 2) N-cad appears necessary for timely movement of glial community.

Um bom modelo experimental deve contar com métodos de avaliação eficazes de seus parâmetros. Esta é uma observação importante quando se faz necessária a avaliação da nocicepção e da incapacitação articular em animais experimentais. O estabelecimento de novos critérios aos testes animais é fundamental para que processos inflamatórios articulares possam continuar sendo estudados, entendidos e resolvidos. Buscando contribuir neste sentido, este trabalho realizou a padronização do teste de incapacitação dinâmico (TID) para avaliação da incapacitação articular em modelos experimentais de artrite. Os resultados obtidos mostram que o TID é sensível na avaliação da incapacitação articular em modelos de artrite induzida por antígeno (AIA) ou por zimosana. Além disso é preditivo para o estudo do efeito farmacológico de drogas que interfiram na incapacitação articular como anti-inflamatórias ou analgésicas. Desde o início da década de 90, quando participação das células da glia na dor foi descrita, diversos trabalhos surgiram mostrando seu papel em diferentes modelos animais. A participação das células da glia espinais na dor e incapacitação em modelos experimentais de artrite e artrite reumatoide têm sido relatada, mas não há descrição desta participação em função do tempo de indução do processo inflamatório articular. Por meio de ferramentas farmacológicas e moleculares, este trabalho mostra que as células da glia, tanto espinais como do gânglio da raiz dorsal estão participando na gênese e manutenção da incapacitação inflamatória articular em modelo de AIA. A participação destas células ocorre por meio da liberação de IL-1? e TNF? em nível medular e pela primeira vez é mostrado que a ativação astrocítica parece preceder a ativação microglial neste modelo. / A good experimental model must rely on effective methods of evaluation of its parameters. This is an important observation when it is necessary to evaluate the articular nociception and disability in experimental animals. Establishing new criteria to test animals is essential for inflammatory joint can continue being studied, understood and resolved. Seeking help in this sense, this work constitutes a test dynamic weight bearing (DWB) standardization for assessment of articular incapacitation in experimental models of arthritis. The results show that the DWB is sensitive in assessing the impairment models articular antigen-induced arthritis (AIA) or zimosana. Furthermore is predictive for studying the pharmacological effects of drugs that interfere with articular incapacitation as antiinflammatory or analgesic. Since the early 90s, when participation of glial cells in pain was described, several studies have emerged showing its role in different animal models. The involvement of glial cells in the spinal pain and disability in experimental models of arthritis and rheumatoid arthritis have been reported, but no description of this contribution versus time of induction of joint inflammation. Through molecular and pharmacological tools, this work shows that the glial cells, both as the spinal dorsal root ganglio are participating in the genesis and maintenance of inflammatory joint incapacitation in AIA model. The participation of these cells occurs through the release of IL-1? and TNF? in the spinal cord and the first time it is shown that astrocytic activation appears to precede the microglial activation in this model.

Gliomas constituem um grupo heterogêneo de tumores cerebrais. Eles podem ser divididos em duas principais categorias: astrocíticos e oligodendrogliais. Os astrocíticos, objetos deste estudo, são classificados patologicamente em quatro subtipos baseado na presença ou ausência de atipia nuclear, mitose, neovascularização e necrose. Esta classificação é útil para definir tratamento e prognóstico. A origem glial é comumente confirmada pela detecção imunoistoquímica para GFAP. Neste trabalho nós investigamos o imunoconteúdo das proteínas marcadoras astrocíticas GFAP e S100B por ELISA e a atividade da enzima glutamina sintetase (GS) em tumores gliais e tecidos peritumorais de sete pacientes submetidos à ressecção cirúrgica. Os resultados demonstram elevados níveis de S100B em tecidos peritumorais não correlacionados com o grau de malignidade do tumor. Esta elevação poderia contribuir para manifestações convulsivas observadas em alguns pacientes. Em contraste com os dados obtidos pela imunoistoquímica para filamentos gliais, encontrou-se uma aparente correlação positiva entre o conteúdo de GFAP e o grau de malignidade do glioma. É possível que este aumento no conteúdo de GFAP seja referente a GFAP total (frações solúvel e insolúvel), em contraste com o conteúdo insolúvel (fibrilar e granular) detectado pela imunoistoquímica. A alta taxa GFAP/S100B (GFAP elevada/S100B reduzida) está de acordo com a sua elevada atividade mitótica, que pela sua vez poderia ser inibida pela S100B. Além disso, houve uma correlação positiva entre a atividade da GS e o grau de malignidade do tumor.

The central nervous system is a complex, yet well-organised, often laminated, tissue. This robust organisation is evident in the architecture of the retina: consisting of 5 different neuronal types organised into distinct layers: Retinal Ganglion Cell (RGC), Amacrine Cell (AC), Bipolar Cell (BP), Horizontal Cell (HC) and Photoreceptor cell (PR) layers. This remarkable organisation is evolutionarily conserved in vertebrates, yet little is known about the mechanisms by which these cells form the correct layers. Live imaging has revealed overlapping periods of birth and extensive inter-digitation followed by cells sorting out into their appropriate positions, suggesting cell-cell interactions are important. To investigate possible cellular and molecular mechanisms responsible for the establishment of the tissue architecture I developed an organoid culture system for zebrafish retinal cells. To identify the cells in culture I used a Spectrum of Fates fish line which is a multiply transgenic line in which each retinal cell type can be identified based on expression of a combination of fluorescently tagged cell fate markers. The development of the protocol by which I cultured the cells and observed their cell-cell interactions involved establishing the best methods to dissociate and culture zebrafish retinal cells in a non-adhesive environment, then imaging the resulting reaggregates to examine the position of the different retinal cell types. By doing this I observed their inherent self-organising properties, in the absence of extrinsic cues or scaffolds. These cells appeared to be arranged in an inside-out layering, although all cell types are layered in the same relative order as they are in vivo. To analyse the organization in these aggregates I developed a Matlab script in collaboration with Leila Muresan which analyses the relative positioning of cells in concentric rings from the periphery to the centre of the aggregates according to the cell fate-tagged fluorescent markers. The script then fits this data as an empirical cumulative distribution function for different groups of cells to determine how spatially distinct populations of cells are. This gave me my measure of organisation. I then investigated the cell-cell interactions involved in this self-organisation by genetically or pharmacologically removing individual cell types and assaying the resulting organisation of the reaggregated, cell-type deficient, retinal organoids. I revealed that Müller Glia are important for retinal cell self-organisation. I also investigated the role of Retinal Pigment Epithelial (RPE) cells and Retinal Ganglion Cells and found they had no impact on the ability of the remaining cell types to organize. I began to investigate the role of Amacrine Cells but found that retinas void of ACs were susceptible to disaggregating in our dissection setup, preventing me from collecting the material needed for culture. I also investigated the role of candidate molecules in this system and revealed that R-Cognin is critical for retinal cells to reaggregate. Not only can I remove cells or molecules from the system, but I show how it can also be manipulated to replace molecules of interest such as laminin, by coating beads with the substance of choice and placing it amongst the cells to see if their organisational behaviour is affected. In summary, I have developed a system which provides a simple and easy platform to manipulate in various ways to help us potentially reveal some of the important players in neuronal patterning.